Description
A hepatoprotective agent; reduces viral DNA and the secretion of HBsAg and HBeAg by 59 and 35%, respectively, in infected 2.2.15 HepG2 cells; reduced DHBV DNA in DHBV-infected ducks at doses ≥0.4 g/kg; reduces the expression of TNF-α and the accumulation of lymphocytes in the liver in a mouse model of concanavalin A-induced liver injury; prevents formation of DEN/PB-induced hepatocellular carcinomas; reduces liver fibrosis in a rat model of bile duct ligation-induced hepatic fibrosis
Formal name: 5′-(hydroxymethyl)-7,7′-dimethoxy-[4,4′-bi-1,3-benzodioxole]-5-carboxylic acid, methyl ester
Synonyms:
Molecular weight: 390.3
CAS: 118159-48-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Research Area|Cancer||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Infectious Disease|Viral Diseases|Hepatitis